Holen Sie sich die Stockscreener-App
2.48
0.80%
-0.02
Handel nachbörslich:
2.50
0.02
+0.81%
Schlusskurs vom Vortag:
$2.50
Offen:
$2.47
24-Stunden-Volumen:
285.89K
Relative Volume:
1.05
Marktkapitalisierung:
$71.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.14M
KGV:
-2.6957
EPS:
-0.92
Netto-Cashflow:
$-12.64M
1W Leistung:
-1.20%
1M Leistung:
+18.10%
6M Leistung:
+52.15%
1J Leistung:
+79.71%
1-Tages-Spanne:
$2.31
$2.49
1-Wochen-Bereich:
$2.31
$2.82
52-Wochen-Spanne:
$1.34
$3.12
Immix Biopharma Inc Stock (IMMX) Company Profile
Firmenname
Immix Biopharma Inc
Sektor
Branche
Telefon
(888) 958-1084
Adresse
11400 WEST OLYMPIC BLVD., LOS ANGELES
Vergleichen Sie IMMX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
2.48 | 82.59M | 0 | -14.14M | -12.64M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times
Immix Biopharma, Inc. to Present at Guggenheim Healthcare Innovation Conference on November 11, 2025 - Quiver Quantitative
Nov 11 Fireside Chat 12:30 ET — Immix Biopharma to Present at Guggenheim Healthcare Conference - Stock Titan
Why Immix Biopharma Inc. stock could benefit from AI revolution2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
Is Immix Biopharma Inc. reversing from oversold territoryChart Signals & Daily Market Momentum Tracking - newser.com
Using AI based signals to follow Immix Biopharma Inc.2025 Price Targets & Low Risk Entry Point Tips - newser.com
Risk adjusted return profile for Immix Biopharma Inc. analyzed2025 Key Highlights & Smart Money Movement Alerts - newser.com
Is Immix Biopharma Inc. stock poised for growthPortfolio Performance Summary & Safe Entry Trade Signal Reports - newser.com
How to monitor Immix Biopharma Inc. with trend dashboardsMarket Activity Summary & Accurate Entry/Exit Alerts - newser.com
What analysts say about Immix Biopharma Inc stockSector-Based Investing & Low Cost Wealth Strategies - earlytimes.in
Using flow based indicators on Immix Biopharma Inc.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-10 06:23:37 - newser.com
How to integrate Immix Biopharma Inc. into portfolio analysis tools2025 Year in Review & Expert Verified Movement Alerts - newser.com
Multi factor analysis applied to Immix Biopharma Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Analyzing drawdowns of Immix Biopharma Inc. with statistical tools2025 Volume Leaders & AI Driven Stock Movement Reports - newser.com
Will Immix Biopharma Inc. stock outperform growth indexesWall Street Watch & Reliable Intraday Trade Alerts - newser.com
Immix Biopharma's (IMMX) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Will Immix Biopharma Inc. benefit from macro trendsJuly 2025 Gainers & Free Real-Time Volume Trigger Notifications - newser.com
Comparing Immix Biopharma (NASDAQ:IMMX) & Candel Therapeutics (NASDAQ:CADL) - Defense World
Is Immix Biopharma Inc a good long term investmentLong-Term Investment Plans & Exceptional Profit Trading - earlytimes.in
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting - GlobeNewswire
Immix Biopharma, Inc. to Present NXC-201 Abstract at ASH 67th Annual Meeting - Quiver Quantitative
NXC-201 Abstract: Immix Biopharma to Present at ASH 67th Annual Meeting in Orlando Dec 6-9, 2025 - Stock Titan
Why Immix Biopharma Inc. stock appeals to analysts2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com
Measuring Immix Biopharma Inc.’s beta against major indicesAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Immix Biopharma Inc. stock chart pattern explainedEntry Point & Verified Short-Term Plans - newser.com
Analyzing Immix Biopharma Inc. with multi timeframe chartsMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Will breakout in Immix Biopharma Inc. lead to full recoveryMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference - The Manila Times
Immix Biopharma, Inc. to Host Investor Meetings at 37th Annual Piper Sandler Healthcare Conference - Quiver Quantitative
Clinical-Stage Cell Therapy Developer ImmixBio to Showcase AL Amyloidosis Pipeline at Major Healthcare Conference - Stock Titan
Real time pattern detection on Immix Biopharma Inc. stockJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immix Biopharma Inc-Aktie (IMMX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S | CFO |
Sep 16 '25 |
Buy |
1.97 |
2,600 |
5,122 |
290,659 |
| Rachman Ilya M | CEO and Chairman |
Jun 18 '25 |
Buy |
2.29 |
2,178 |
4,999 |
1,138,437 |
| Morris Gabriel S | CFO |
Jun 18 '25 |
Buy |
2.28 |
2,225 |
5,071 |
288,059 |
| Hsu Jason | Director |
Dec 23 '24 |
Buy |
2.19 |
40,000 |
87,680 |
893,000 |
| Hsu Jason | Director |
Dec 20 '24 |
Buy |
2.17 |
7,700 |
16,678 |
853,000 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):